Status | Study |
Completed |
Study Name: Efficacy and Safety of Peginesatide in the Treatment of Anemia in Patients With Chronic Kidney Disease Condition: Anemia Chronic Kidney Disease Chronic Renal Failure Date: 2006-04-13 Interventions: Drug: peginesatide Other Names: Omontys Hematide AF37 |
Completed |
Study Name: Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias Condition: Anemia, Aplastic Amegakaryocytic Thrombocytopenia Diamond- Date: 2005-10-24 Interventions: Device: Allogeneic stem cell transplant Participants will receive a reduced intensity conditioning regim |
Completed |
Study Name: Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia Condition: Anemia, Aplastic Red-Cell Aplasia, Pure Date: 2005-09-29 Interventions: Drug: Rituximab Rituximab (Rituxan) 375mg/m2 intravenous infusion. The infusion will be once every week |
Completed |
Study Name: A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins Condition: Red-Cell Aplasia, Pure Date: 2005-09-13 |
Completed |
Study Name: A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment Condition: Pure Red-cell Aplasia Date: 2005-09-13 Interventions: Other: No intervention This is an observational study. No medication will be given to the participants. |
Completed |
Study Name: Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin Condition: Red-Cell Aplasia, Pure Chronic Renal Failure Date: 2005-09-13 Interventions: Other: No Intervention Participants will not receive any intervention in this study. Participants with c |
Completed |
Study Name: A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa Condition: Pure Red-cell Aplasia Date: 2005-09-13 Interventions: Drug: No intervention This study is an observational study. No medication will be provided or administer |
Recruiting |
Study Name: Diamond Blackfan Anemia Registry (DBAR) Condition: Anemia Blood Disease Date: 2005-03-18 |
Recruiting |
Study Name: Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias Condition: Congenital Hemolytic Anemia Diamond-Blackfan Anemia Date: 2003-05-29 Interventions: Procedure: Radiotherapy Drug: Alemtuzumab |
Completed |
Study Name: Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia Condition: Diamond Blackfan Anemia Date: 2001-02-22 Interventions: Drug: G-CSF Procedure: Leukapheresis |